Application

14982934 · FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF

Filed 2015-12-29 · Granted · Patent 9867873 (2018-01-16) The official file ↗The patent and its PDF ↗ · Art unit 1644 · Examiner Michael Edward Szperka Typical · CPC A61K 38/36 · Bioverativ Therapeutics Inc. · Lathrop Gage LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

8.2 mo

to disposition 24.6 mo

Statutes raised

103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.